Form D · Other
Fount Bio, Inc.
Cambridge, MA · CIK 0001872597
Offering snapshot reported Jul 16, 2021 · SEC filing
- Reported sold
- $8.16M Offering amount: $8.16M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2021 | Initial | $8,157,203 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-406519
Source: Form D, filed Jul 16, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Aiudi | Director |
| Justin Burns | Director |
| Douglas Levinson | Director, Executive |
| Samir Mitragotri | Director |
Issuer details
Industry: Other (See others in industry)
Address:
325 Vassar St.
Cambridge, MA, 02139
Cambridge, MA, 02139